Author correction to ‘Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo’ [Acta Pharmaceutica Sinica B 11 (2021) 3950–3965]

Detalles Bibliográficos
Autores principales: Deng, Linglong, Petrek, Hannah, Tu, Mei-Juan, Batra, Neelu, Yu, Ai-Xi, Yu, Ai-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465936/
https://www.ncbi.nlm.nih.gov/pubmed/37655312
http://dx.doi.org/10.1016/j.apsb.2023.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465936/
https://www.ncbi.nlm.nih.gov/pubmed/37655312
http://dx.doi.org/10.1016/j.apsb.2023.07.002

Ejemplares similares